Close Menu

NEW YORK – RNAi therapeutics firm Alnylam Pharmaceuticals and consumer genetics firm 23andMe will offer free genetic test kits to first-degree family members of 23andMe customers who have a TTR variant known to cause hereditary amyloidosis.

Hereditary ATTR amyloidosis (hATTR) is caused by a build up of the transthyretin protein that can damage tissues and organs. The condition is inherited but is rare and hard to diagnose. Late diagnosis can result in poor patient outcomes.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.